Table 5.
Baseline values and the mean within-group changes at weeks 6 and 12 in skeletal muscle power, cardiorespiratory fitness, and physical function outcomes according to randomized allocation.
| DM (n = 8) | EX+DM (n = 9) | EX (n = 10) | CON (n = 10) | |
|---|---|---|---|---|
| CMJ (cm) | ||||
| Baseline | 17.1 (8.4–28.0) | 13.5 (3.0–21.0) | 17.0 (10.3–24.2) | 19.2 (10.3–26.0) |
| 6 weeks | 17.3 (7.5–22.3) | 14.0 (3.3–22.1) | 18.0 (12.0–24.0) | 18.2 (10.3–26.0) |
| 12 weeks | 17.6 (6.7–24.0) | 15.1 (2.3–29.0) | 18.5 (13.3–24.0) | 19.1 (11.0–25.2) |
| CMJ (W/kg BM) | ||||
| Baseline | 28.9 (21.3–39.6) | 25.4 (16.2–33.0) | 31.7 (24.0–36.2) | 29.7 (20.3–38.5) |
| 6 weeks | 28.5 (16.7–34.1) | 25.4 (14.5–35.0) | 31.0 (24.6–40.0) | 30.2 (20.4–38.5) |
| 12 weeks | 29.0 (16.3–33.0) | 28.2 (15.0–38.0) | 31.4 (27.2–36.0) | 30.5 (20.6–37.0) |
| Gait speed (m/s) | ||||
| Baseline | 0.95 (0.80–1.20) | 0.81 (0.60–1.10) | 0.84 (0.70–1.00) | 0.80 (0.70–0.90) |
| 6 weeks | 0.83 (0.70–1.00) | 0.84 (0.70–1.10) | 0.85 (0.60–1.00) | 0.84 (0.70–1.00) |
| 12 weeks | 0.81 (0.60–0.90) | 0.81 (0.60–0.90) | 0.80 (0.60–1.00) | 0.80 (0.70–0.90) |
| Submaximal VO2 (ml/kg BM/min) | ||||
| Baseline | 17.0 (11.6–22.3) | 15.6 (9.7–21.5) | 21.5 (17.0–26.0) | 25.0 (17.0–33.0) |
| 6 weeks | 17.6 (7.0–28.3) | 17.0 (5.0–28.6) | 20.0 (13.0–27.0) | 27.2 (15.6–39.0) |
| 12 weeks | 18.2 (8.5–27.6) | 18.0 (5.7–30.0) | 20.2 (12.0–28.6) | 24.0 (11.0–37.1) |
Values shown are the mean (95% CI).
DM, high-protein dairy milk beverage; EX, exercise; EX+DM, exercise and high-protein dairy milk beverage; CON, control; BM, body mass; CMJ, countermovement jump; FFM, fat-free mass; VO, maximal oxygen consumption.